Drug · DIN 02408929
MINT-CLOPIDOGREL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since March 24, 2022.
- Drug Identification Number (DIN)
- 02408929
- Company (DIN owner)
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Clopidogrel B01AC04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CLOPIDOGREL (CLOPIDOGREL BISULFATE) | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 24, 2022: NOC 27832Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies
- July 12, 2013: NOC 14547Abbreviated New Drug Submission (ANDS)
Other DINs named MINT-CLOPIDOGREL
- DIN 02408910 · Marketed